EV/EBITDA:
-12.84+0.21(+1.61%)Summary
- As of today (September 13, 2025), SPRY EV/EBITDA is -12.84, with a rise of +0.21 (+1.61%) during the most recent trading session on September 12, 2025.
- Over the past year, SPRY EV/EBITDA has increased by +4.91 (+27.66%).
- SPRY EV/EBITDA is now -648.72% below its all-time high of 2.34.
Performance
SPRY EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SPRY EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.6% | -1.6% | -1.2% |
| 1 m1 month | +46.6% | -46.5% | -39.8% |
| 3 m3 months | +70.0% | -33.9% | -30.4% |
| 6 m6 months | +95.9% | -15.6% | -18.5% |
| ytdytd | +94.9% | +4.6% | -4.9% |
| 1 y1 year | +27.7% | -25.2% | -20.6% |
| 5 y5 years | - | - | - |
SPRY EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -12.84 | at high | -24.03 | +46.6% |
| 3 m | 3-month | -12.84 | at high | -56.86 | +77.4% |
| 6 m | 6-month | -12.84 | at high | -379.17 | +96.6% |
| 1 y | 1-year | -12.84 | at high | -397.77 | +96.8% |
| 3 y | 3-year | 2.34 | -648.7% | -397.77 | +96.8% |
| 5 y | 5-year | 2.34 | -648.7% | -397.77 | +96.8% |
| alltime | all time | 2.34 | -648.7% | -397.77 | +96.8% |
SPRY EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -12.84(-94.9%) |
| 2024 | -250.24(+5523.4%) |
| 2023 | -4.45(-64.1%) |
| Date | Value |
|---|---|
| 2022 | -12.40(-7850.0%) |
| 2021 | 0.16(-100.3%) |
| 2020 | -52.07 |
FAQ
- What is ARS Pharmaceuticals, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for ARS Pharmaceuticals, Inc.?
- What is SPRY EV/EBITDA year-to-date change?
- What is ARS Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is ARS Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of SPRY is -12.84
What is the all time high EV/EBITDA for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high EV/EBITDA is 2.34
What is SPRY EV/EBITDA year-to-date change?
ARS Pharmaceuticals, Inc. EV/EBITDA has changed by +237.40 (+94.87%) since the beginning of the year
What is ARS Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, SPRY EV/EBITDA has changed by +4.91 (+27.66%)